Treatment Outcomes after Postoperative Radiotherapy in Triple-Negative Breast Cancer: Multi-Institutional Retrospective Study (KROG 17-05)

  • 0Department of Radiation Oncology, Dongsan Hospital, Keimyung University School of Medicine, 1035 Dalgubeol-daero Dalseo-gu, Daegu 42601, Republic of Korea.

|

|

Summary

This summary is machine-generated.

Postoperative radiotherapy for triple-negative breast cancer (TNBC) in South Korea showed high survival rates. T and N stages, lympho-vascular invasion, and Ki-67 expression are key prognostic factors for patient outcomes.

Area Of Science

  • Oncology
  • Radiotherapy
  • Breast Cancer Research

Background

  • Triple-negative breast cancer (TNBC) presents unique challenges in treatment and prognosis.
  • Postoperative radiotherapy (PORT) is a critical component of TNBC management.
  • Understanding failure patterns and prognostic factors after PORT is essential for improving patient outcomes.

Purpose Of The Study

  • To investigate failure patterns, survival rates, and prognostic factors in South Korean TNBC patients receiving PORT.
  • To identify key clinical and biological factors influencing outcomes after PORT for TNBC.

Main Methods

  • A multi-institutional retrospective study involving 699 TNBC patients who underwent PORT.
  • Data collected from six institutions between 2008 and 2010, with a median follow-up of 94 months.
  • Analysis included overall survival, loco-regional relapse-free survival (LRRFS), distant metastasis-free survival (DMFS), and disease-free survival (DFS).

Main Results

  • Patients achieving pathologic complete remission after neoadjuvant chemotherapy showed no treatment failure.
  • Distant metastasis was the primary cause of treatment failure.
  • Five-year survival rates: overall (91.4%), LRRFS (92.3%), DMFS (89.4%), and DFS (85.2%).
  • T and N stages, lympho-vascular invasion (LVI), and Ki-67 expression were significant prognostic factors.

Conclusions

  • T and N stages, LVI, and Ki-67 expression are significantly associated with survival outcomes in TNBC patients post-PORT.
  • These factors can aid in risk stratification and personalized treatment strategies for TNBC.